Abstract

ObjectivesTo replicate previous analyses on the effectiveness of the English human papillomavirus (HPV) vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) using 12 additional...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
HPV vaccination in south Asia: new progress, old challenges.
The Lancet Oncology
The Lancet. Oncology | VOL. 23
The Lancet Oncology The Lancet Oncology
01 Oct 2022
Trends and future projections of cervical cancer-related outcomes in Japan: What happens if the HPV vaccine program is not implemented?
Yutaka Ueda ... Koichi Terakawa
International journal of cancer | VOL. 152
Yutaka Ueda, et. al.Yutaka Ueda ... Koichi Terakawa
22 Dec 2022
Impact of the human papillomavirus vaccine in low-resource settings
Gad Murenzi ... Chemtai Mungo
The Lancet Global Health | VOL. 11
Gad Murenzi, et. al.Gad Murenzi ... Chemtai Mungo
16 May 2023
Global strategy to eliminate cervical cancer as a public health problem: are we on track?
Eclinicalmedicine
EClinicalMedicine | VOL. 55
Eclinicalmedicine Eclinicalmedicine
01 Jan 2023
View more papers

More From: BMJ

Paper Title
Journal
Date
Author
New WHO guidance can support transparent and informed engagement with the private sector
Kent Buse ... Monika Arora
BMJ | VOL. 385
Kent Buse, et. al.Kent Buse ... Monika Arora
29 May 2024
Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders
Matthew Limb
BMJ | VOL. 385
Matthew LimbMatthew Limb
29 May 2024
Sudan: Aid workers describe “bloodbath” in Darfur as hospitals are repeatedly attacked
Elisabeth Mahase
BMJ | VOL. 385
Elisabeth MahaseElisabeth Mahase
29 May 2024
US state classifies mifepristone and misoprostol as dangerous controlled substances
Janice Hopkins Tanne
BMJ | VOL. 385
Janice Hopkins TanneJanice Hopkins Tanne
29 May 2024
View more papers